Dodecadenia grandiflora
Dodecadenia grandiflora · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Dodecadenia grandiflora is a botanical species that has garnered significant scientific interest due to its unique therapeutic potential. Research indicates that extracts derived from the plant's leaves possess notable antihyperglycemic activities. These extracts appear to influence metabolic pathways, specifically targeting the Glucose-6-Phosphatase enzyme. By modulating such biochemical processes, the plant demonstrates a capacity to assist in the management of blood sugar levels. Consequently, this species serves as a promising subject for further pharmacological investigation into natural diabetes treatments.
- Synonyms
- Laurus Pallens · Litsea Grandiflora · 4 more
- Common names
- Not available
- Family
- Lauraceae
- Distribution
- Southern America
- Plant Parts
- Leaf
Classification
Common Names
Dodecadenia grandiflora is a unique botanical species recognized by various regional names across different languages. In certain European contexts, it is known by the common name dvanástnica veľkokvetá. Meanwhile, in Chinese-speaking regions, the plant is referred to as 单花木姜子. These diverse designations highlight the global interest and varied linguistic interpretations of the species. Understanding these relationships helps researchers and enthusiasts identify the plant regardless of their cultural background.
Sources: Catalogue of Life (COL)
Synonyms
Dodecadenia grandiflora is a botanical subject characterized by a complex web of taxonomic synonyms. This species is frequently identified in scientific literature through names such as Actinodaphne monantha and Dodecadenia griffithii. Variations within the plant also include the specific designation of Dodecadenia grandiflora var. griffithii. Furthermore, historical or alternative classifications may link it to Laurus macrophylla or Laurus pallens. Navigating these overlapping botanical relationships is essential for accurate species identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Dodecadenia grandiflora is a remarkable botanical specimen that belongs to the vast kingdom Plantae. Within this diverse kingdom, it is classified under the class Equisetopsida and the order Laurales. This plant is further distinguished as a member of the specific genus Dodecadenia. Ultimately, it finds its place within the esteemed family Lauraceae. Together, these biological classifications provide a clear understanding of its unique position in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Laurales |
| Family | Lauraceae |
| Genus | Dodecadenia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Dodecadenia grandiflora exhibits a diverse geographical range that spans both temperate and tropical regions of Asia. Within the temperate zones, this plant is notably found throughout various parts of China, including the South-Central regions and Tibet. Its presence extends into tropical climates across the Indian Subcontinent, where it thrives in areas such as Assam and Bangladesh. Additionally, the species can be located within the unique ecological niche of the East Himalaya. This wide distribution highlights the plant's ability to adapt to varying environmental conditions across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Dodecadenia grandiflora is a self-supporting plant that exhibits a distinct tree-like growth form. This species is capable of reaching a maximum height of 12 meters in its natural habitat. Its sturdy structure allows it to stand prominently within its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Dodecadenia grandiflora has demonstrated significant antihyperglycemic activity through the presence of specific phenylpropanoyl esters and lignane dimers. Research involving bioactivity-guided separation of leaf extracts has identified several key compounds, such as catechol glycosides, that contribute to this medicinal effect. When tested in streptozotocin-induced diabetic rats, these bioactive compounds exhibited potency comparable to the standard pharmaceutical drug metformin. These findings are crucial because they provide a scientific basis for the plant's historical use by traditional medical practitioners to manage blood sugar. Ultimately, the identification of these specific chemical structures helps validate the therapeutic potential of the species in treating diabetes.
Compounds
Conditions
Dodecadenia grandiflora exhibits significant antihyperglycemic activity through its various phenylpropanoyl esters and lignane bis(catecol glycoside)esters. These bioactive compounds demonstrate the plant's ability to treat glucose-6-phosphatase by inhibiting the enzyme with notable efficacy. In experimental models, the extracts from the leaves of Dodecadenia grandiflora successfully treat streptozotocin-induced (STZ) diabetic rats. The medicinal potency of these specific compounds is comparable to the standard drug metformin. Consequently, these biochemical interactions provide a scientific basis for the traditional use of the plant as an antihyperglycemic agent.
Preparations
Dodecadenia grandiflora is prepared as an extract from its leaves to explore its medicinal properties. This specific extract underwent bioactivity-guided separation to isolate various phenylpropanoyl esters and lignane bis(catecol glycoside)esters. These isolated compounds demonstrated significant antihyperglycemic activity when tested in diabetic rat models. The potency of the extract's components is notably comparable to the standard drug metformin. Such findings scientifically validate the traditional use of the plant extract as an antihyperglycemic agent.
Parts used
Dodecadenia grandiflora contains specific bioactive compounds that are primarily concentrated within its leaves. Research involving the phytochemical investigation of these leaves has led to the identification of several significant phenolic glycosides. These isolated compounds, including various phenylpropanoyl esters, have demonstrated potent antihyperglycemic activity in laboratory models. Specifically, the extracts have shown a capacity to inhibit glucose-6-phosphatase, a key enzyme in metabolic regulation. These findings provide a scientific basis for the traditional medicinal use of the plant's foliage in managing blood sugar levels.